On Thursday, the Nigeria Center for Disease Control (NCDC) announced a new guideline for the treatment and discharge of COVID-19 pandemic patients for case management.
It was made known to the Presidential Task Force on COVID-19 (PTF) media briefing in Abuja, by Dr. Chikwe Ihekweazu, Director-General of NCDC.
Ihekweazu said the third version of the guidelines was released after new science has emerged on the duration of individual patients’ infectivity.
The director-general said the recommendations are for patients with symptoms and asymptoms.
Symptomatic patients will now be discharged at least 10 days after the onset of symptoms and at least 3 days without symptoms, he says.
“The asymptomatic patients may discharge them 14 days after the first positive PCR test.
“You don’t have to wait any longer for a negative result to be released, with the assurance that you can go home, and that you’re no longer dangerous or endangering family or friends.
“If your symptoms last longer we ‘re going to wait to manage them,” Ihekweazu said.
Ihekweazu said the doctors were hesitant about the new guidelines, assuring them the new guidelines would be effective.
The NCDC chief said the centre had also removed the use of antivirals and Chloroquine and hydroxychloroquine from its treatment guidelines.
He said the antivirals would now be used only on trials setting and casually because its safety